Scientists from the Wuhan Institute of Virology and Fudan University (China) suggest using one of the antibodies discovered during the 2003 SARS epidemic to neutralize the new coronavirus.
According to TASS, the CR3022 antibody, attaches well to the new 2019-nCoV coronavirus.
Scientists have noticed the RBD protein, which the virus uses to penetrate human cells. According to scientists, it will be possible to influence it with a drug based on CR3022 antibody.
Scientists are now studying patient blood samples, hoping to discover other antibodies that will bind more actively to the virus than CR3022.
Scientists from the Doherty Institute managed to obtain a copy of the 2019-nCoV coronavirus in the laboratory. The virus was isolated from the tissues of the first patient with a confirmed diagnosis.